Results

Total Results: 1,583 records

Showing results for "liver".
Users also searched for: hepatitis c

381. Filespecifications Nis 2002 10Pct Severity B
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/FileSpecifications_NIS_2002_10PCT_SEVERITY_B.TXT
     January 01, 2002 - NIS 2002 10PCT_SEVERITY_B 23 CM_LIVER 86 87 Num AHRQ comorbidity measure: Liver

382. Filespecifications Nis 2002 10Pct Severity A
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/FileSpecifications_NIS_2002_10PCT_SEVERITY_A.TXT
     January 01, 2002 - NIS 2002 10PCT_SEVERITY_A 23 CM_LIVER 86 87 Num AHRQ comorbidity measure: Liver

383. Filespecifications Kid 2006 Severity
     hcup-us.ahrq.gov/db/nation/kid/tools/stats/FileSpecifications_KID_2006_Severity.txt
     January 01, 2006 - KID 2006 Severity 24 CM_LIVER 85 86 Num AHRQ comorbidity measure: Liver

384. Filespecifications Kid 2003 Severity
     hcup-us.ahrq.gov/db/nation/kid/tools/stats/FileSpecifications_KID_2003_SEVERITY.TXT
     January 01, 2003 - KID 2003 SEVERITY 24 CM_LIVER 85 86 Num AHRQ comorbidity measure: Liver

385. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0398_06-17-2008.pdf
     January 01, 2008 - ESA resistance, malnutrition-inflammation complex syndrome, or other co-morbid conditions such as liver

386. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49617/psn-pdf
     January 01, 2011 - age, gender, weight, muscle metabolism, and protein intake.(4) Specifically, patients with end-stage liver … Scr may not reflect renal function in patients with reduced muscle mass, malnutrition, and end-stage liver

387. Kbjjfcap9Xvhkp43U-7B9Q (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KbJjfcaP9XvhkP43u-7b9q
     July 01, 2014 - The largest trial (n � 658), which enrolled Asian pa- tients with more advanced liver disease, heavily … Lamivudine for patients with chronic hepatitis B and advanced liver disease. … Hui CK, Leung N, Shek WH, Zhang HY, Luk JM, Poon RT, et al; Hong Kong Liver Fibrosis Study Group. … progression to liver complications. … Screening for liver cancer: results of a randomised controlled trial in Qidong, China.

388. Case Report on Ambulatory Safety and Quality (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/quality-resources/tools/lab-testiing/lab-testing-casereport.pdf
     September 05, 2017 - Abnormal electrolyte levels may be a sign of dehydration, kidney disease, liver disease, heart failure … Urea Nitrogen (BUN) A waste product of the liver excreted by the kidneys. … Liver disease and heart attacks, as well as serious physical injury can cause elevation of these … Alkaline Phosphatase A bone and liver enzyme. … High values are associated with liver and gall-bladder disease.

389. Racial Misclassification and Disparities in Mortality among AI/AN and Other Races, Washington
     hcup-us.ahrq.gov/datainnovations/raceethnicitytoolkit/or26.jsp
     August 01, 2014 - were in the top five causes for Whites, but did not appear in the top five for AI/ANs, while chronic liver … Unintentional injury and chronic liver disease were notable for even higher disparities (rate ratios … From least to most common causes, for 1990 to 1999, AI/AN: chronic lower respiratory disease, chronic liver … are all causes, C V D, cancer, unintentional injury, chronic lower respiratory disease, and chronic liver

390. Archived: Hepatitis B in Pregnant Women: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-in-pregnant-women-screening-2009
     June 15, 2009 - infections increase long-term morbidity and mortality by predisposing infected persons to cirrhosis of the liver … and liver cancer.

391. Fiber-Intake-Final-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-c.xlsx
     January 01, 2024 - Community 40–65 y; BMI 20–35 kg/m2, habitual WG consumption <24 g/d Diabetes, heart, renal, bowel, liver … COI) Community nonsmoking, weight-stable males aged 35–55 y history or presence of kidney disease, liver … , use of medication for dyslipidaemia, T2D or hypertension, diseases including gastrointestinal and liver … the food provided in the study; with or history of endocrine, cardiovascular, arterial hypertension, liver … Pregnancy, Allergies including food allergies, Metal implants, Chronic disease of heart, kidney, or liver

392. Appendix C: Fiber Intake and Laxation in People With Normal Bowel Function Report (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-c.xlsx
     January 01, 2024 - Community 40–65 y; BMI 20–35 kg/m2, habitual WG consumption <24 g/d Diabetes, heart, renal, bowel, liver … , use of medication for dyslipidaemia, T2D or hypertension, diseases including gastrointestinal and liver … the food provided in the study; with or history of endocrine, cardiovascular, arterial hypertension, liver … Pregnancy, Allergies including food allergies, Metal implants, Chronic disease of heart, kidney, or liver … COI) Community nonsmoking, weight-stable males aged 35–55 y history or presence of kidney disease, liver

393. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49486/psn-pdf
     August 21, 2005 - Second, warfarin is metabolized in the liver by the P450 cytochrome CYP2C9. … approximately 7 to 9 days before the warfarin level or INR reaches a steady state.(4) Patients with liver … factors associated with lower warfarin requirements include a body mass index (BMI) less than 20, liver

394. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix F2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
     January 01, 2018 - Placebo-Controlled Trials WAE WAE SAE SAE CV Events CV Events CV Events CV Events GI GI GI GI Liver … Dysfunction Liver Dysfunction Liver Dysfunction Liver Dysfunction Renal Dysfunction Renal Dysfunction … Acetaminophen - Placebo-Controlled Trials WAE WAE SAE SAE Liver Toxicity Liver Toxicity Liver … Toxicity Liver Toxicity Author, Year Quality Pain Population Drug Assessment Time (wk) Time Category … Dysfunction Liver Dysfunction Liver Dysfunction Liver Dysfunction Renal Dysfunction Renal Dysfunction

395. Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Service Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/TkWNoq6KQb3SoZ54gscLCQ
     July 25, 2016 - Clin Liver Dis (Hoboken). 2018;12(1):1-4. doi:10.1002/cld. 732 7. … Hui CK, Leung N, Shek WH, et al; Hong Kong Liver Fibrosis Study Group. … progression to liver complications. … Efficacy of low-dose alpha interferon therapy in HBV-related chronic liver disease in Asian Indians: … Lamivudine for patients with chronic hepatitis B and advanced liver disease.

396. Pc2015
     hcup-us.ahrq.gov/toolssoftware/procedure/pc2015.csv
     January 01, 2012 - BIOPSY 1 '5012' OPEN LIVER BIOPSY 3 '5013' TRANSJUGULAR LIVER BX (Begin 2007) 1 '5014' LAPAROSCOPIC … HEPATECTOMY 4 '5023' OPN ABLTN LIVER LES/TISS (Begin 2006) 4 '5024' PERC ABLTN LIVER LES/TIS (Begin … 2006) 4 '5025' LAP ABLTN LIVER LES/TISS (Begin 2006) 4 '5026' ABLTN LIVER LES/TISS NEC (Begin 2006 … TRANSPL 4 '5059' LIVER TRANSPLANT NEC 4 '5061' CLOSURE LIVER LACERAT 4 '5069' LIVER REPAIR NEC 4 … '5091' PERCUTAN LIVER ASPIRAT 2 '5092' EXTRACORPOR HEPAT ASSIS 2 '5093' LOCAL PERFUSION LIVER 2 '

397. CDS Connect Implementation Guide Draft (doc file)
     cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
     October 01, 2017 - to be excepted from statin therapy if the case is mild or resolved (i.e., resolved Hepatitis A, mild liver … Patients with active liver disease or hepatic disease or insufficiency. … Denominator exception "Active liver disease or hepatic disease or insufficiency" eCQM logic represents … this phrase as 3 distinct data elements: Liver Disease, Hepatitis A, and Hepatitis B. … in the ACC/AHA guidelines as a contraindication for statins and has been used as a proxy for severe liver

398. HCUP-3 Nationwide Inpatient Sample for 1994: Principal Diagnoses
     hcup-us.ahrq.gov/reports/natstats/94dcchpr.htm
     November 01, 1998 - Cancer of rectum 47,258 0.14 10.52 21,700 and anus 16 Cancer of liver … intestinal abscess 149 Biliary tract disease 532,428 1.54 4.63 11,415 150 Liver … disease, 60,138 0.17 8.13 16,949 alcohol-related 151 Other liver

399. Statistics From the HCUP-3 Nationwide Inpatient Sample for 1993: Principal Diagnoses
     hcup-us.ahrq.gov/reports/natstats/93dcchp.htm
     March 10, 2016 - Cancer of rectum 49,489 0.14 11.12 21,581 and anus 16 Cancer of liver … intestinal abscess 149 Biliary tract disease 540,842 1.56 4.74 10,925 150 Liver … disease, 53,388 0.15 8.63 16,101 alcohol-related 151 Other liver

400. Neds 2018 Ip Maskedstats (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2018_IP_MaskedStats.PDF
     January 01, 2018 - MAJ O.R. 8,409 0.17 4: TRACH W MV >96 HRS OR PDX EXC FACE, MOUTH & NECK W/O MAJ O.R. 6,800 0.13 5: LIVER … TRANSPLANT W MCC OR INTESTINAL TRANSPLANT 149 0.00 6: LIVER TRANSPLANT W/O MCC 25 0.00 7: LUNG TRANSPLANT … , LIVER & SHUNT PROCEDURES W/O CC/MCC 85 0.00 408: BILIARY TRACT PROC EXCEPT ONLY CHOLECYST W OR W/O … EXCEPT MALIG,CIRR,ALC HEPA W MCC 11,617 0.23 442: DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W CC … 13,014 0.26 443: DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W/O CC/MCC 3,580 0.07 444: DISORDERS